Effect of Pantoprazole on the Symptoms of Acid Reflux Disease in Adult Patients (BY1023/M3-341)
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The aim of the present study is to identify factors (such as symptom patterns and symptom
scores) that influence the response to treatment with pantoprazole using different evaluation
methods (e.g., ReQuest™ questionnaire, patient and investigator assessment). Pantoprazole
will be administered once daily in the morning at one dose level. The study duration consists
of a treatment period of 8 weeks. The study will provide further data on safety and
tolerability of pantoprazole.